Olam NewsAug 21, 2025

Takeda Chooses India for Global Clinical Trials

Takeda Pharmaceutical explores global clinical trials in India to accelerate launches of cancer drugs, dengue vaccines, and digital innovation.

https://www.olamnews.com/health/637/https-www-olamnews-com-international-takeda-global-trials-india/

Takeda Chooses India for Global Clinical Trials - Olam News

Takeda Pharmaceutical explores global clinical trials in India to accelerate launches of cancer drugs, dengue vaccines, and digital innovation.

Olam News
The Japan TimesJan 30, 2025
Julie Kim is set to replace Christophe Weber as the new CEO of Takeda Pharmaceutical, becoming the first woman to lead the more than 240-year-old Japanese drugmaker. https://www.japantimes.co.jp/business/2025/01/30/companies/takeda-first-female-ceo/?utm_medium=Social&utm_source=mastodon #business #companies #takedapharmaceutical #juliekim #christopheweber #pharmaceuticals
Takeda picks first female CEO of centuries-old drugmaker

Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval, the company said.

The Japan Times
BongolianJul 24, 2024

Terrence McCoy, Júlia Ledur & Marina Dias: How ‘carbon cowboys’ are cashing in on protected Amazon forest: A six-month investigation reveals that many carbon credit ventures reap profits from public lands they have no right to and fail to share revenue with those protecting the forest.

#Netflix, #AirFrance, #DeltaAirLines, #Salesforce, #PricewaterhouseCoopers, #Airbnb, #TakedaPharmaceutical Co., #BostonConsulting, #Spotify, #Boeing.
#giftarticle #amazonrainforest #carboncredits #ClimateChange #CorporateGreed #fraud
https://wapo.st/4fhK2ft

In Brazil’s Amazon, carbon credit traders cash in on public forests

A six-month investigation reveals that many carbon credit ventures reap profits from public lands they have no right to and fail to share revenue with those protecting the forest.

The Washington Post
The Japan TimesFeb 28, 2024
Japan's Takeda Pharmaceutical is holding talks with Indian regulators to make its dengue vaccine available in the country. https://www.japantimes.co.jp/business/2024/02/28/companies/takeda-dengue-vaccine-india/ #business #companies #takedapharmaceutical #pharmaceuticals #india #health #vaccinations #denguefever
Takeda in regulatory talks to launch dengue vaccine in India

Takeda's dengue vaccine is currently available for children and adults in countries like Indonesia, Thailand, Argentina and Brazil.

The Japan Times
The Japan TimesOct 7, 2023
A Japanese-led research team has said it has identified how infections with the coronavirus can cause inflammation in blood vessels and blood clots, resulting in severe COVID-19 cases. https://www.japantimes.co.jp/news/2023/10/07/japan/science-health/covid-severe-cases-research/?utm_content=bufferb8807&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #osakauniversity #tokyomedicalanddentaluniversity #takedapharmaceutical #medicine #health #covid19 #covid19injapan
Japan-led team identifies how severe COVID-19 cases develop

The research results are expected to facilitate the development of drugs to prevent serious COVID-19 complications.

The Japan Times